Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN966757 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Protein P53 (TP53) (pSer46) antibody
- Antigen
- The antiserum was produced against synthesized phosphopeptide derived from human p53 around the phosphorylation site of serine 46 (M-L-SP-P-D).
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 100ug
- Concentration
- 100ug/100ul.
- Storage
- Store at -20°C/1 year.
Submitted references Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
A decade of CDK5.
p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
Mayo LD, Seo YR, Jackson MW, Smith ML, Rivera Guzman J, Korgaonkar CK, Donner DB
The Journal of biological chemistry 2005 Jul 15;280(28):25953-9
The Journal of biological chemistry 2005 Jul 15;280(28):25953-9
HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V, Soddu S, Sacchi A, D'Orazi G
Oncogene 2005 Aug 18;24(35):5431-42
Oncogene 2005 Aug 18;24(35):5431-42
A decade of CDK5.
Dhavan R, Tsai LH
Nature reviews. Molecular cell biology 2001 Oct;2(10):749-59
Nature reviews. Molecular cell biology 2001 Oct;2(10):749-59
p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
Patrick GN, Zhou P, Kwon YT, Howley PM, Tsai LH
The Journal of biological chemistry 1998 Sep 11;273(37):24057-64
The Journal of biological chemistry 1998 Sep 11;273(37):24057-64
No comments: Submit comment
No validations: Submit validation data